Fondazione IRCCS Istituto Nazionale dei Tumori
The Istituto Nazionale dei Tumori is Italy's national cancer institute and a leader in sarcoma, thoracic oncology, and immunotherapy.
Sarcoma reference centre, HIPEC/peritoneal surgery, early-phase trials.
- Sarcoma
- Peritoneal surface malignancy
Sarcoma surgeon who led the ISG-STS 1001 trial of histology-tailored neoadjuvant chemotherapy.
Filippo de Braud heads medical oncology and the phase 1 programme at Italy's national cancer institute.
Marco Guzzo is a head and neck surgeon at INT Milan.
Pages like this
not linked directly; found by shared links- IdeaA same-week expert second opinion for every rare cancer diagnosis
Shares Marco Guzzo, Alessandro Gronchi, Sarcomas (soft tissue, bone, GIST).
- TrialISG-STS 1001
Shares Alessandro Gronchi, Sarcomas (soft tissue, bone, GIST).
- InstitutionEuropean Society of Surgical Oncology
Shares Alessandro Gronchi, HIPEC / PIPAC (intraperitoneal chemotherapy).
- InstitutionPoliclinico Universitario A. Gemelli
Shares Fondazione AIRC per la ricerca sul cancro, IRCCS Regina Elena National Cancer Institute.
- InstitutionIEO – European Institute of Oncology
Shares Fondazione AIRC per la ricerca sul cancro, IRCCS Ospedale San Raffaele.
- InstitutionSociety of Surgical Oncology
Shares HIPEC / PIPAC (intraperitoneal chemotherapy), Sarcomas (soft tissue, bone, GIST).